Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Claeson

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Analytical Biochemistry|February 1, 1981
Sensitive enzyme assays based on the production of chemiluminescent leaving groupsB R Branchini, J D Hermes, F G Salituro, et al.
Circulatory Shock|January 1, 1985
Efficacy of S-2441, a synthetic oligopeptide, in a rat model for gram-negative bacteremiaJ U Balis, J F Paterson, J Fareed, et al.
The Journal of Biological Chemistry|March 5, 1993
In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitorC Tapparelli, R Metternich, C Ehrhardt, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Design of novel types of thrombin inhibitors based on modified D-Phe-Pro-Arg sequencesG Claeson, S Elgendy, L Cheng, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
The use of isosteric bonds in the design of thrombin inhibitorsM F Scully, J Deadman, L Cheng, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptidesG Claeson, J Fareed, C Larsson, et al.
The Biochemical Journal|March 1, 1993
Benzyloxycarbonyl-D-Phe-Pro-methoxypropylboroglycine: a novel inhibitor of thrombin with high selectivity containing a neutral side chain at the P1 positionG Claeson, M Philipp, E Agner, et al.
Journal of Medicinal Chemistry|April 28, 1995
Characterization of a class of peptide boronates with neutral P1 side chains as highly selective inhibitors of thrombinJ J Deadman, S Elgendy, C A Goodwin, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Analytical Biochemistry|February 1, 1981
Sensitive enzyme assays based on the production of chemiluminescent leaving groupsB R Branchini, J D Hermes, F G Salituro, et al.
Circulatory Shock|January 1, 1985
Efficacy of S-2441, a synthetic oligopeptide, in a rat model for gram-negative bacteremiaJ U Balis, J F Paterson, J Fareed, et al.
The Journal of Biological Chemistry|March 5, 1993
In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitorC Tapparelli, R Metternich, C Ehrhardt, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Design of novel types of thrombin inhibitors based on modified D-Phe-Pro-Arg sequencesG Claeson, S Elgendy, L Cheng, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
The use of isosteric bonds in the design of thrombin inhibitorsM F Scully, J Deadman, L Cheng, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptidesG Claeson, J Fareed, C Larsson, et al.
The Biochemical Journal|March 1, 1993
Benzyloxycarbonyl-D-Phe-Pro-methoxypropylboroglycine: a novel inhibitor of thrombin with high selectivity containing a neutral side chain at the P1 positionG Claeson, M Philipp, E Agner, et al.
Journal of Medicinal Chemistry|April 28, 1995
Characterization of a class of peptide boronates with neutral P1 side chains as highly selective inhibitors of thrombinJ J Deadman, S Elgendy, C A Goodwin, et al.
Pageof 3